Monoclonal Mouse anti‑Human IL17B Antibody (Biotin, Extracellular Domain, WB) LS‑C70960
Monoclonal Mouse anti‑Human IL17B Antibody (Biotin, Extracellular Domain, WB) LS‑C70960
Antibody:
IL17B Mouse anti-Human Monoclonal (Extracellular Domain) (Biotin) Antibody
Format:
Biotin, Unmodified
Overview
Antibody:
IL17B Mouse anti-Human Monoclonal (Extracellular Domain) (Biotin) Antibody
Format:
Biotin, Unmodified
Specifications
Description
IL17B antibody LS-C70960 is a biotin-conjugated mouse monoclonal antibody to human IL17B (Extracellular Domain). Validated for ELISA and WB.
Target
Human IL17B
Synonyms
IL17B | Cytokine Zcyto7 | Cytokine-like protein ZCYTO7 | IL-17B | Interleukin 17B | Interleukin 20 | Interleukin-17 beta | Interleukin-17B | NIRF | Interleukin-20 | ZCYTO7
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG2b
Monoclonal
Purification
Protein G purified
Immunogen
NS0-derived recombinant human rhIL-17B R extracellular domain.
Epitope
Extracellular Domain
Specificity
Recognizes human IL-17B R.
Applications
- Western blot (1 - 2 µg/ml)
- ELISA (0.5 - 2 µg/ml)
Usage
Suitable for use in ELISA and Western Blot. ELISA: 0.5-2 ug/mL. Western Blot:1-2 ug/ml. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
Presentation
Lyophilized PBS, BSA
Reconstitution
Reconstitute in deionized water
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot
Species:
Human
Applications:
Western blot
Species:
Human, Rat
Applications:
IHC - Paraffin, ELISA
Reactivity:
Human
Range:
24-1500 pg/ml
Reactivity:
Rat
Range:
15.63-1000 pg/ml
Source:
E. coli
Tag:
His, N-Terminal
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/26/2024